← Back to headlines
Illumina CEO Discusses Genomic Sequencing and AI Opportunities
Illumina CEO Jacob Thaysen discussed the company's earnings, opportunities in genomic medicine, and the potential applications of artificial intelligence in life sciences.
31 Jul, 20:47 — 31 Jul, 20:47
